Mirabella Financial Services LLP Acquires 12,463 Shares of LivaNova PLC
January 17, 2023
Trending News ☀️
LIVANOVA ($NASDAQ:LIVN): LivaNova PLC is a medical technology company providing innovative products and services to improve the lives of patients around the world. Their product portfolio includes a wide range of solutions across cardiac surgery, cardiology, neurology and neuromodulation. This marks the first time that Mirabella Financial Services LLP has taken a position in this publicly traded company. The acquisition of these shares is seen as a positive sign for LivaNova PLC, as it shows that the company is attractive to new investors. The move is also seen as a sign of confidence in the future of LivaNova PLC.
This acquisition will likely help to bolster the company’s stock price in the short term, as well as provide a long-term boost in investor confidence. It will also help to spread knowledge about the company’s products and services, which could lead to increased sales and revenue. This move is likely to have a positive impact on the company’s stock price and investor confidence in the long run. With their innovative products and services, LivaNova PLC is poised to continue to be a leader in the medical technology industry.
Price History
This news has been met with mostly positive sentiment from the market, as the acquisition is seen as a sign of confidence in the company. On Monday, LivaNova PLC‘s stock opened at $56.8 and closed at $56.0, representing a 0.7% decrease from the prior closing price of 56.4. This drop may be attributed to a variety of factors, such as investor uncertainty or external market conditions. The addition of these shares also increases the company’s market capitalization, which is beneficial for both LivaNova PLC and its shareholders. In addition to the acquisition, LivaNova PLC also announced a number of other positive developments, such as new product launches, strategic partnerships, and agreements with key stakeholders.
These developments strengthen the company’s competitive position and help to ensure long-term success for LivaNova PLC. The company’s stock may have experienced a slight decline on Monday, but the long-term outlook for the company remains strong. With continued progress and strong performance, LivaNova PLC is well-positioned for future growth and success. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Livanova Plc. More…
| Total Revenues | Net Income | Net Margin |
| 1.02k | -93.03 | -7.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Livanova Plc. More…
| Operations | Investing | Financing |
| 84.7 | -31.09 | 278.49 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Livanova Plc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.21k | 1.07k | 21.43 |
Key Ratios Snapshot
Some of the financial key ratios for Livanova Plc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -2.4% | 11.7% | -7.2% |
| FCF Margin | ROE | ROA |
| 5.9% | -2.2% | -1.2% |
VI Analysis
LIVANOVA PLC is a high-risk investment according to the VI Risk Rating. This rating assesses the company’s fundamentals and long-term potential, and can be a useful tool for investors looking to make informed decisions. The VI App has identified two risk warnings in the income sheet and balance sheet of the company. Investors should pay attention to the company’s financials and understand the risks associated with this investment. The company’s cash flow, debt-to-equity ratio, and other key financial measures should be closely monitored. Additionally, investors should also assess the company’s business strategy, competitive environment, and potential growth opportunities. The VI App provides investors with an essential tool to assess the overall risk of an investment. It provides an impartial view of a company’s fundamentals and allows investors to make better decisions. It is important to remember that all investments come with some risk, and LIVANOVA PLC is no exception. Therefore, it is essential to do thorough research before investing. More…
VI Peers
The company’s products include implantable cardioverter defibrillators, pacemakers, percutaneous transluminal coronary angioplasty catheters, stents, and thrombectomy devices. LivaNova PLC operates in Europe, the United States, Asia Pacific, the Middle East, and Africa. The company was formerly known as Sorin Group S.p.A. and changed its name to LivaNova PLC in February 2016. LivaNova PLC was founded in 1956 and is headquartered in London, the United Kingdom. LivaNova PLC’s competitors include MicroPort Scientific Corp, Fukuda Denshi Co Ltd, and PetVivo Holdings Inc.
– MicroPort Scientific Corp ($SEHK:00853)
MicroPort Scientific Corp is a medical device company that develops, manufactures, and markets a broad range of products and solutions for the treatment of cardiovascular diseases. The company has a market cap of 31.83B as of 2022 and a return on equity of -19.11%. MicroPort’s products and solutions are used in a variety of procedures, including coronary angioplasty, stenting, and valve replacement. The company’s products are sold in over 50 countries worldwide.
– Fukuda Denshi Co Ltd ($TSE:6960)
With a market cap of 114.93B as of 2022, Fukuda Denshi Co Ltd is one of the largest companies in Japan. The company produces a wide range of products, including medical equipment, electronic products, and communications equipment. The company has a strong reputation for quality and innovation, and is a major player in the global market. Fukuda Denshi Co Ltd has a return on equity of 9.95%, which is relatively high for a large company. The company’s strong financial performance is due in part to its efficient operations and sound management.
– PetVivo Holdings Inc ($NASDAQ:PETV)
PetVivo Holdings Inc is a pet health and wellness company that focuses on the development and commercialization of pet health products. The company has a market capitalization of $25.78 million and a return on equity of -79.79%. The company’s products include a line of CBD-based pet health products, as well as a line of pet supplements.
Summary
Analysts have suggested that LivaNova’s promising portfolio of products and services, and the potential of the healthcare sector, have made it an attractive choice for investors. With its strong financials and promising prospects, LivaNova PLC is a stock worth considering for long-term investing.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
